COBRA工具开发:助力基层早期识别类风湿关节炎风险人群
本研究基于英国医学研究理事会复杂干预研究框架,通过定性描述研究、临床医生参与工作坊和有声思维访谈三个阶段开发COBRA工具,以支持在基层医疗中实施临床预测模型识别抗CCP阳性且类风湿关节炎风险人群。
要点
- COBRA工具包含临床决策支持系统、使用指导、证据支持和患者教育资源四个核心组件。
- 临床医生认为COBRA工具可辅助决策并减少不必要的抗CCP检测。
- 工具开发经过多阶段临床医生参与和原型测试,共完成超过40处修改。
核心结论
- 基于复杂干预研究框架开发了COBRA工具,以支持基层医疗中临床预测模型的实施,促进类风湿关节炎风险人群的早期识别。
研究设计与样本
- 采用英国医学研究理事会和国家健康与护理研究所复杂干预研究框架,分三个阶段:定性描述研究、临床医生咨询参与工作坊和有声思维访谈研究。
主要发现
- 通过访谈识别了实施障碍和促进因素,初步提出九个候选干预组件。
- 工作坊中四个组件被优先列为「必须有」或「应该有」:临床决策支持系统、使用指导/相关行动、证据支持、患者教育资源。
- 有声思维访谈中,临床医生认为COBRA工具的主要益处包括支持决策和减少不必要的抗CCP检测。
- 原型测试后对COBRA工具进行了超过40处修改。
关键数值与推荐
- 优先组件包括临床决策支持系统(CDSS)、CDSS使用指导/相关行动、CDSS证据、患者教育资源。
临床怎么用
- COBRA工具可用于基层医疗,辅助临床医生决策,识别可能抗CCP阳性且类风湿关节炎风险人群,并减少不必要的抗CCP检测。
局限性
- 研究仅涉及基层临床医生和PPI代表,未报告工具对临床结局影响的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to develop a new complex intervention, the 'COuld it Be RA' (COBRA) tool, to support the implementation of a clinical prediction model to identify people likely to be anti-cyclic citrullinated peptide (CCP) positive and at risk of rheumatoid arthritis in primary care. METHODS: The COBRA tool was developed using the UK Medical Research Council and National Institute for Health and Care Research complex intervention research framework. This study involved three sequential phases with primary care clinicians: a qualitative descriptive study, clinician consultation engagement workshops and a think-aloud interview study. Ethical approval was obtained for all three phases. RESULTS: Sixteen primary care clinicians participated in semistructured interviews to identify barriers and facilitators. An initial list of nine candidate components for the intervention, including design considerations, was developed. During phase 2 workshops with eight participants, four components were prioritised as 'Must have' or 'Should have': the clinical decision support system (CDSS); guidance on using the CDSS/associated actions; evidence for the CDSS; patient education resources. A COBRA tool prototype incorporating these components was developed.Twelve participants tested the prototype during think-aloud interviews. Key perceived benefits of the COBRA tool included supporting clinicians' decision-making and reducing unnecessary anti-CCP testing. Over 40 changes were made to the COBRA tool. CONCLUSION: Our research included the views of clinicians and PPI representatives and was underpinned by a complex intervention research framework. This was critical to understanding barriers and facilitators to implementing the clinical prediction model in primary care and developing the COBRA tool.
引用
- Siddle HJ, Anderson AM, Hensor EMA, et al. Development of the 'COuld it Be RA' (COBRA) tool to facilitate early identification of people at risk of developing rheumatoid arthritis in primary care. RMD Open. 2026. PMID: 41692508. doi:10.1136/rmdopen-2025-005957
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。